Merck wins FDA approval for overactive bladder OTC treatment in women
News | 28 January 2013
Select a Pharmaceutical sector, ------------------------, Fine & Speciality Chemicals, Manufacturing, Process & Production, OTC, ------------------------, Drug Delivery, Drug Discovery & Development, ------------------------, Clinical Trials, Contract ...
Click on the link to read the full article at Pharmaceutical Business Review
(This link will open in a new window)
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
